<DOC>
	<DOCNO>NCT01966601</DOCNO>
	<brief_summary>To evaluate overall safety efficacy TRV027 administer addition standard care ( SOC ) mortality , morbidity , dyspnea , length stay patient hospitalize Acute Decompensated Heart Failure ( ADHF ) .</brief_summary>
	<brief_title>A Study Explore Efficacy TRV027 Patients Hospitalized Acute Decompensated Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1 . Men woman age ≥21 year ≤ 85 year 1a.Women nonchildbearing potential 2 . Able provide write informed consent 3 . Preexisting diagnosis heart failure least 30 day treatment daily oral loop diuretic 4 . Systolic blood pressure ≥105 mmHg ≤ 160 mmHg within 30 minute randomization 5 . Ventricular rate ≤125 bpm . Patients ratecontrolled persistent permanent atrial fibrillation ( aFib ) screening permit . 6 . Presence ADHF define : BNP &gt; 400 pg/mL NTproBNP &gt; 1600 pg/mL For patient BMI &gt; 30 kg/m2 : BNP &gt; 200 pg/mL NTproBNP &gt; 800 pg/mL For patient ratecontrolled persistent permanent aFib : BNP &gt; 600 pg/mL NTproBNP &gt; 2400 pg/mL Congestion chest radiograph ( CXR ) AND least two ( 2 ) following : Rales chest auscultation Edema ≥ +1 03 + scale , indicate indentation skin mild digital pressure require 10 second resolve dependent area include extremity sacral region . Elevated jugular venous pressure ( ≥8 cm H2O ) 7 . Receipt IV loop diuretic minimum dose 40 mg furosemide ( equivalent loop diuretic ) treatment dyspnea due ADHF least 1 hour prior anticipate randomization initiation study medication 8 . Patient report dyspnea rest upon minimal exertion screen least one hour administration IV loop diuretic 1 . Women pregnant breastfeed 2 . Clinical presentation : 1 . Suspected ACS base clinical judgment 2 . Coronary revascularization 3 month prior screen plan current admission . 3 . Temperature &gt; 38.5oC 4 . Clinically significant anemia 5 . Serum sodium &gt; 145 mEq/L ( 145 mmol/L ) 6 . Current planned ultrafiltration , paracentesis , hemofiltration dialysis time screen 7 . Any mechanical ventilation 8 . CPAP/BiPAP discontinue less 1 hour prior randomization 9 . History LVAD IABP within last year 10 . Intravenous radiographic contrast agent within 72 hour prior screen presence acute contrast induce nephropathy time screen 11 . Presence clinically significant arrhythmia 12 . Uncertainty ability complete follow 3 . Medications : 1. nitroprusside nesiritide 2 . Intravenous nitrate 3. use inotropes 4 . Use ARBs within 7 day prior randomization 5 . Use investigational medication within 30 day 6. clinically significant hypersensitivity allergy , intolerance , angiotensin receptor blocker 4 . Medical history : 1 . Major surgery within 8 week prior screen 2 . Stroke within 3 month prior screen 3. eGFR ( sMDRD ) &lt; 20 mL/min/1.73m2 &gt; 75 mL/min/1.73m2 presentation randomization 4 . Post cardiac renal transplant 5 . Listed renal transplant cardiac transplant anticipate transplant time transplant &lt; 6 month 6 . History severe leave ventricular outlet obstruction ( either valvular subvalvular ) , severe mitral valve stenosis severe aortic regurgitation 7 . Cardiac valvular abnormality require surgical correction 8 . Complex congenital heart disease 9 . Hypertrophic restrictive cardiomyopathy 10. significant pulmonary hepatic disease could interfere evaluation safety efficacy TRV027 11. life expectancy le 6 month</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>